supor aef 0.2 µm intravenous filter

2
Supor ® AEF 0.2 μm Intravenous Filter Air-eliminating filter set designed for 24-hour infusion drug delivery Features 0.2 µm Supor (polyethersulfone) membrane. Low protein binding. Compatible with all standard clinical infusion regimens, including those utilizing infusion and syringe pumps. Sterile and non-pyrogenic fluid pathway. Free of natural rubber latex. Non-phthalate fluid pathway. Benefits Reduces inadvertent particulate debris and eliminates entrained air that may be found in intravenous solutions for a maximum of 24 hours. Minimal adsorption to the membrane. Will not introduce undesirable extract- ables into the infusion preparation. Use with continuous infusions as well as with intermittent infusions or injections. 11.6916

Upload: others

Post on 16-Oct-2021

8 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Supor AEF 0.2 µm Intravenous Filter

Supor® AEF 0.2 µm Intravenous Filter

Air-eliminating filter set designed for 24-hour infusiondrug delivery Features

0.2 µm Supor (polyethersulfone) membrane.

Low protein binding.

Compatible with all standard clinical infusion regimens, including those utilizing infusion and syringe pumps.

Sterile and non-pyrogenic fluid pathway.

Free of natural rubber latex. Non-phthalatefluid pathway.

BenefitsReduces inadvertent particulate debrisand eliminates entrained air that may be found in intravenous solutions for a maximum of 24 hours.

Minimal adsorption to the membrane.

Will not introduce undesirable extract-ables into the infusion preparation.

Use with continuous infusions as well aswith intermittent infusions or injections.

11.6916

Page 2: Supor AEF 0.2 µm Intravenous Filter

The information provided in this literature was reviewed for accuracy at the time of publication. Product data may be subject to change without notice. For current information consult your local Pall distributor or contact Pall directly.

© 2011, Pall Corporation. Pall, and Supor are trademarks of Pall Corporation. ® indicates a registered trademark in the USA. Filtration.Separation.Solution. is a service mark of Pall Corporation.

International OfficesPall Corporation has offices and plants throughout the world in locations such as: Argentina, Australia, Austria,Belgium, Brazil, Canada, China, France, Germany, India, Indonesia, Ireland, Italy, Japan, Korea, Malaysia, Mexico, the Netherlands, New Zealand, Norway, Poland, Puerto Rico, Russia, Singapore, Spain, Sweden, Switzerland,Taiwan, Thailand, the United Kingdom, the United States, and Venezuela. Distributors in all major industrial areas of the world.

Visit us on the Web at www.pall.com

7/11, xK, GN11.6916 11.6916

United States25 Harbor Park DrivePort Washington, NY 11050

1.866.347.3428 toll free phone (USA)1.516.484.5400 phone

EuropePall International SàrlAvenue de Tivoli 3 1700 Fribourg, Switzerland

+41 (0)26 350 53 00 phone+41 (0)26 350 53 53 [email protected] email

DescriptionUsageSingle patient use

24-hour maximum useCan be used with continuous infusions or intermittent infusions/ injections

Materials of Construction Filter Media: 0.2 µm Supor (polyethersulfone) membrane Filter Housing: Acrylic

Air Elimination Two 0.02 µm hydrophobic membranes

SterilizationSterile and non-pyrogenic fluid pathway. Gamma sterilized.

Internal Volume of Filter0.7 mL

Maximum Working Pressure30 psi (1,500 mm Hg, 2 bar)

Bubble Point≥ 46 psi (2,380 mm Hg, 3.1 bar)

Hold-up Volume Plus Tubing Extension(where applicable)AEF1E - approximately 1.0 mLAEF1NTE - approximately 0.7 mL

Flow Rates 0.9% (w/v) Saline at 1 m InfusionAEF1E - approximately 9 mL/min.AEF1NTE - approximately 12 mL/min.

Bacterial RetentionRetentive of B. diminuta and meets USP 25/NF20 requirements for a sterilizing grade filter per ASTM F838-05test methods.

Biological SafetyHas been evaluated in accordance with USP Class VI-121ºCplastic tests and/or relevant sections of the ISO 10993 seriesof standards to ensure biological safety of the materials.

Inadvertent contamination of intravenous infusionscan have serious consequences:

• Particulate Contamination – Arisesfrom a variety of sources, intrinsicallyin infusate and equipment, andextrinsically due to manipulations.Studies have demonstrated thatparticles may cause phlebitis.1

• Entrained Air – Results fromdegassing of solutions, incompletepriming, or with disconnection.Entrained air is especially problematic on central line, leading to air emboli.2

• Microbial Contamination – of IV administration systems arisesinadvertently due to manipulations.3

Some bacteria can grow rapidly in infusion fluids, increasing theinfection risk.4,5

Ordering InformationSupor AEF low protein binding intravenous filter for 24-houruse, female luer inlet and male luer outlet.

Part Number Description Pkg QtyAEF1E Supor AEF low protein binding Individually 50/case

intravenous filter set for 24-hour use, packagedinlet female luer connector, outletmicrobore tubing, slide clamp, and male luer connector

AEF1NTE Supor AEF low protein binding Individually 50/caseintravenous filter set for 24-hour use, packagedinlet female luer connector and outlet male luer connector with rotating collar

References1. Falchuk KH, Peterson L, McNeil BJ. New England Journal of

Medicine, 1985; 312:78-82.

2. Coppa GF, Gouge TH, Hofstetter SR. J Parenteral Enteral Nutr.1981;5:166-8.

3. Groves MJ. Parenteral Technology Manual, 2nd ed., InterpharmPress, 1989.

4. Holmes, CJ, Kundsin RB, Ausman RK, Walter CW. J Clin Microbiol.1980; 12:725-31.

5. Bozzetti F, Bonfanti G, Regalia E. Nutri Clin Pract. 1990; 5:156-9.